Skip to content

Clinical trials

Phase 3 Metabolic Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Phase 3 Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20102
20161
20201
20223
20231
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.3
Agios Pharmaceuticals, Inc.2
AstraZeneca2
Pfizer2
Regeneron Pharmaceuticals2
Diamyd Medical AB1
Eli Lilly and Company1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Rezolute1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases16
Diabetes Mellitus7
Glucose Metabolism Disorders7
Diabetes Mellitus, Type 26
Endocrine System Diseases5
Digestive System Diseases3
Anemia2
Arthritis2
Body Weight2
Fatty Liver2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.